文献速递头颈部肿瘤放疗

口腔鳞癌术后保留吞咽功能:放疗体积效应随机II期试验方案

Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial.
PubMed 文献 · Radiat Oncol · 2020-08-14

PRESERVE研究为多中心随机II期试验,计划入组90例T1-4 N0-2期口腔鳞癌术后至少一侧颈清扫pN0的患者,按1:2随机分配至标准放疗体积组或省略pN0半颈放疗组。主要终点为pN0半颈区域失败,假设2年区域复发≤20%,次要终点包括总生存、无进展生存、局部复发、挽救治疗率、毒性和生活质量。

要点

  • PRESERVE研究评估口腔鳞癌术后省略pN0半颈放疗对区域失败的影响。
  • 主要终点假设pN0半颈2年区域复发≤20%,对照历史数据。
  • 计划随机90例,标准体积与省略pN0半颈放疗按1:2分配。

核心结论

  • 本研究旨在评估口腔鳞癌术后省略pN0半颈放疗的区域失败率,并与历史对照比较。
  • 同时比较标准放疗体积与省略pN0半颈放疗在肿瘤结局、毒性和生活质量上的差异。
  • 结果将为未来确证性III期试验设计提供依据。

研究设计与样本

  • 多中心随机II期试验,计划入组90例T1-4 N0-2期口腔鳞癌术后至少一侧颈清扫pN0的患者。
  • 按1:2随机分配至标准放疗体积组或省略pN0半颈放疗组。
  • 按总体淋巴结状态(有或无淋巴结受累)和是否同步化疗进行分层。

主要发现

  • 主要终点为pN0半颈区域失败,假设2年区域复发≤20%。
  • 次要终点包括总生存、无进展生存、局部复发、挽救治疗率、毒性和生活质量。

关键数值与推荐

  • 入组条件为T1-4 N0-2期口腔鳞癌术后至少一侧颈清扫pN0。
  • 主要终点假设pN0半颈2年区域复发≤20%。
  • 随机分组比例为标准放疗体积组:省略pN0半颈放疗组=1:2。

临床怎么用

  • 若结果支持,省略pN0半颈放疗可能减少吞咽相关毒性和改善生活质量。
  • 研究结果将指导未来III期试验的设计。

局限性

  • 本文件为研究方案,尚无实际结果数据。
  • 主要终点采用历史对照,非直接随机比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with resected oral cavity squamous cell carcinoma (OCSCC) are often treated with adjuvant radiation (RT) ± concomitant chemotherapy based on pathological findings. Standard RT volumes include all surgically dissected areas, including the tumour bed and dissected neck. RT has significant acute and long-term toxicities including odynophagia, dysphagia, dermatitis and fibrosis. The goal of this study is to assess the rate of regional failure with omission of radiation to the surgically dissected pathologically node negative (pN0) hemi-neck(s) compared to historical control, and to compare oncologic outcomes, toxicity, and quality of life (QoL) profiles between standard RT volumes and omission of RT to the pN0 neck. METHODS: This is a multicentre phase II study randomizing 90 patients with T1-4 N0-2 OCSCC with at least one pN0 hemi-neck in a 1:2 ratio between standard RT volumes and omission of RT to the pN0 hemi-neck(s). Patients will be stratified based on overall nodal status (nodal involvement vs. no nodal involvement) and use of concurrent chemotherapy. The primary endpoint is regional failure in the pN0 hemi-neck(s); we hypothesize that a 2-year regional recurrence of 20% or less will be achieved. Secondary endpoints include overall and progression-free survival, local recurrence, rate of salvage therapy, toxicity and QoL. DISCUSSION: This study will provide an assessment of omission of RT to the dissected pN0 hemi-neck(s) on oncologic outcomes, QoL and toxicity. Results will inform the design of future definitive phase III trials. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT03997643 . Date of registration: June 25, 2019, Current version: 2.0 on July 11 2020.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Lang P, Contreras J, Kalman N, et al. Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial. Radiat Oncol. 2020. PMID: 32795322. doi:10.1186/s13014-020-01636-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。